Development of variant‐proof severe acute respiratory syndrome coronavirus 2, pan‐sarbecovirus, and pan‐β‐coronavirus vaccines-Reference-Cited by-同舟云学术

Development of variant‐proof severe acute respiratory syndrome coronavirus 2, pan‐sarbecovirus, and pan‐β‐coronavirus vaccines

Published:2022-10-06 Issue:1 Volume:95 Page:
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Zhou Jie¹,Liu Zezhong¹²,Zhang Guangxu¹,Xu Wei¹,Xing Lixiao¹,Lu Lu¹^ORCID,Wang Qian¹,Jiang Shibo¹^ORCID

Affiliation:

1. Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS) Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences Fudan University Shanghai China

2. Department of Pharmacology, School of Pharmacy Fudan University Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.28172

Reference173 articles.

1. Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England

2. Detection of a SARS-CoV-2 variant of concern in South Africa

3. Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil

4. Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum

5. Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid nanoparticle encapsulation of a Delta spike-CD40L DNA vaccine improves effectiveness against Omicron challenge in Syrian hamsters;Molecular Therapy - Methods & Clinical Development;2024-09

2. Safety and immunogenicity of the SARS-CoV-2 LYB001 RBD-based VLP vaccine (CHO cell) phase 1 in Chinese adults: a randomized, double-blind, positive-parallel-controlled study;Expert Review of Vaccines;2024-05-02

3. A Cocktail of Lipid Nanoparticle-mRNA Vaccines Broaden Immune Responses against β-Coronaviruses in a Murine Model;Viruses;2024-03-21

4. Protective efficacy of a plant-produced beta variant rSARS-CoV-2 VLP vaccine in golden Syrian hamsters;Vaccine;2024-02

5. The Immunogenicity of CpG, MF59-like, and Alum Adjuvant Delta Strain Inactivated SARS-CoV-2 Vaccines in Mice;Vaccines;2024-01-07